Agilent Technologies, Inc.
NYQ: ALive Quote
📈 ZcoreAI Score
Our AI model analyzes Agilent Technologies, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get A Z-Score →About Agilent Technologies, Inc.
Healthcare
Diagnostics & Research
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
📊 Fundamental Analysis
Agilent Technologies, Inc. demonstrates exceptional profitability, with a profit margin of 18.3%.
The company recently reported 7.0% revenue growth, which is modest compared to its industry peers.
Return on Equity (ROE) is 19.9%, which exceeds the Healthcare sector average, reflecting efficient capital allocation.
At a current price of $115.06, A currently sits at the 26th percentile of its 52-week range (Range: $99.12 - $160.27).
💰 Valuation Insight
A is valued broadly in line with the sector at a PE of 25.40. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
✅
Profit Margin
Excellent
⚠️
Debt/Equity
Moderate
🔴
Revenue Growth
Weak
⚠️
Return on Equity
Moderate
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$32.54B
Trailing P/E
25.40
Forward P/E
17.48
Beta (5Y)
1.30
52W High
$160.27
52W Low
$99.12
Avg Volume
2.20M
Day High
Day Low